Overview

Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study

Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of sorafenib administered as later lines of treatment in patients with advanced HCC.
Phase:
Phase 2
Details
Lead Sponsor:
Bo Hyun Kim
Treatments:
Sorafenib